Abstract
Objective
Some evidence exists that patients with osteosarcoma and Ewing sarcoma are taller than the general population. However, previous studies are under-powered, lack comprehensive data and show inconsistencies.
Methods
Relevant studies linking osteosarcoma and Ewing sarcoma with height at diagnosis were identified in two major online databases, Medline (1950 to 2009) and Embase (1980 to 2009). Outcomes in individual studies were reported as standard deviation (SD) scores or percentages of study population with height at diagnosis above the median of the reference population. We performed separate random-effects meta-analyses for each outcome and tumour type.
Results
14 studies examined the height of patients with osteosarcoma or Ewing sarcoma. Meta-analyses on SD scores found patients with osteosarcoma were 0.260 SD (95% CI: 0.088–0.432) taller than the reference population (five studies). A meta-analysis on percentages found 62% (95% CI: 57%–67%) of patients were estimated to have a height above the median (six studies). Patients with Ewing sarcoma were 0.096 SD (95% CI 0.004–0.188) taller (four studies). Only one study reported the percentage of Ewing sarcoma patients with height above the median.
Conclusion
The average height of patients with osteosarcoma, but not Ewing sarcoma, was significantly above the average height of the reference population by 2–3 centimetres. The observed differences indicate the involvement of pubertal longitudinal bone growth in osteosarcoma development while different biological pathways could be relevant for Ewing sarcoma.
Similar content being viewed by others
References
Stiller CA (2007) Childhood Cancer in Britain Incidence, Survival. Oxford University Press, Mortality. Oxford, p 270
Birch JM, Alston RD, Kelsey AM, Quinn MJ, Babb P, McNally RJ (2002) Classification and incidence of cancers in adolescents and young adults in England 1979–1997. Br J Cancer 87:1267–1274
Eng C, Li FP, Abramson DH et al (1993) Mortality from second tumours following long-term survivors of retinoblastoma. J Natl Cancer Inst 85:1121–1128
Porter DE, Holden ST, Steel CM, Cohen BB, Wallace MR, Reid R (1992) A significant proportion of patients with osteosarcoma may belong to Li-Fraumeni cancer families. J Bone Joint Surg Br 74:883–886
Wang LL, Levy ML, Lewis RA et al (2001) Clinical manifestations in a cohort of 41 Rothmund-Thomson syndrome patients. Am J Med Genet 102:11–17
Goto M, Miller RW, Ishikawa Y, Sugano H (1996) Excess of rare cancers in Werner syndrome (adult progeria). Cancer Epidemiol Biomarkers Prev 5:239–246
Tucker MA, D’Angio GJ, Boice JD Jr et al (1987) Bone sarcomas linked to radiotherapy and chemotherapy in children. N Engl J Med 317:588–593
Hawkins MM, Wilson LM, Burton HS et al (1996) Radiotherapy, alkylating agents, and risk of bone cancer after childhood cancer. J Natl Cancer Inst 88:270–278
Fry SA (1998) Studies of U.S. radium dial workers: an epidemiological classic. Radiat Res 150:S21–S29
Koshurnikova NA, Gilbert ES, Sokolnikov M et al (2000) Bone cancers in Mayak workers. Radiat Res 154:237–245
Huvos AG, Butler A, Bretsky SS (1983) Osteogenic sarcoma associated with Paget’s disease of bone. A clinicopathologic study of 65 patients. Cancer 52:1489–1495
Operskalski EA, Preston-Martin S, Henderson BE, Visscher BR (1987) A case-control study of osteosarcoma in young persons. Am J Epidemiol 126:118–126
Frentzel-Beyme R, Becher H, Salzer-Kuntschik KotzR, Salzer M (2004) Factors affecting the incident juvenile tumors in an Austrian case-control study. Cancer Detect Prev 28:159–169
Silcocks PB, Murrells T (1987) Space-time clustering and bone tumours: application of Knox’s method to data from a population-based cancer registry. Int J Cancer 40:769–771
McNally RJ, Kelsey AM, Eden OB, Alexander FE, Cairns DP, Birch JM (2003) Space-time clustering patterns in childhood solid tumours other than central nervous system tumours. Int J Cancer 103:253–258
Valery PC, McWhirter W, Sleigh A, Williams G, Bain C (2003) A national case-control study of Ewing’s sarcoma family of tumours in Australia. Int J Cancer 105:825–830
Holman CDJ, Reynolds PM, Byrne MJJ, Trotter JM, Armstrong BK (1983) Possible infectious etiology of six cases of Ewing’s sarcoma in Western Australia. Cancer 52:1974–1976
Zamora P, Garcia de Paredes ML, Gonzalez Baron M et al (1986) Ewing’s tumor in brothers. An unusual observation. Am J Clin Oncol 9:358–360
Holly EA, Aston DA, Ahn DK, Kristiansen JJ (1992) Ewing’s bone sarcoma, parental occupational exposure, and other factors. Am J Epidemiol 135:122–129
Winn DM, Li FP, Robison LL, Mulvihill JJ, Daigle AE, Fraumeni JF Jr (1992) A case-control study of the etiology of Ewing’s sarcoma. Cancer Epidemiol Biomarkers Prev 1:525–532
Valery PC, McWhirter W, Sleigh A, Williams G, Bain C (2002) Farm exposures, parental occupation, and risk of Ewing’s sarcoma in Australia: a national case-control study. Cancer Causes Control 13:263–270
Hum L, Kreiger N, Finkelstein MM (1998) The relationship between parental occupation and bone cancer risk in offspring. Int J Epidemiol 27:766–771
Cope JU, Tsokos M, Helma LJ, Gridley G, Tucker MA (2000) Inguinal hernia in patients with Ewing sarcoma: a clue to etiology. Med Ped Oncol 34:195–199
Johnson LC (1953) A general theory of bone tumours. Bull N Y Acad Med 29:164–171
Price CHG (1958) Primary bone-forming tumours and their relationship to skeletal growth. J Bone Joint Surg Br 40B:574–593
Withrow SJ, Powers BE, Straw RC, Wilkins RM (2006) Comparative aspects of osteosarcoma dog versus man. Clin Orthop Relat Res 448:193–198
Tjalma RA (1966) Canine bone sarcoma: estimation of relative risk as a function of body size. J Natl Cancer Inst 36:1137–1150
Ru G, Terracini B, Glickman LT (1998) Host related risk factors for canine osteosarcoma. Vet J 156:31–39
Fraumeni JF Jr (1967) Stature and malignant tumours of bone in childhood and adolescence. Cancer 20:967–973
Pui CH, Dodge RK, George SL, Green AA (1987) Height at diagnosis of malignancies. Arch Dis Child 62:495–499
Cotterill SJ, Wright CM, Pearce MS, Craft AW (2004) Stature of young people with malignant bone tumours. Pediatr Blood Cancer 42:59–63
Longhi A, Pasini A, Cicognani A et al (2005) Height as a risk factor for osteosarcoma. J Pediatr Hematol Oncol 27:314–318
Harville DA (1977) Maximum likelihood approaches to variance component estimation and to related problems. J Am Statist Assoc 72:320–338
Lewis S, Clarke M (2001) Forest plots: trying to see the wood and the trees. BMJ 16:1479–1480
Higgins JP, Thompson SG, Deeks JJ, Altman DG (2003) Measuring inconsistency in meta-analyses. BMJ 327:557–560
Thompson SG, Sharp SJ (1999) Explaining heterogeneity in meta-analysis: a comparison of methods. Stat Med 18:2693–2708
Kontonpantelis E, Reeves D (2010) metaan: random-effects meta-analysis. Stata J 10:395–407
Sterne JAC, Egger M, Moher D (2008) Addressing reporting biases. In: Higgins JPT, Green S, eds. Cochrane Handbook for Systematic Reviews of Intervention. Version 5.0.1 (updated September 2008). The Cochrane Collaboration. Available from www.cochrane-handbook.org
Brostrom LA, Adamson U, Filipsson R, Hall K (1980) Longitudinal growth and dental development in osteosarcoma patients. Acta Orthop Scand 51:755–759
Buckley JD, Pendergrass TW, Buckley CM et al (1998) Epidemiology of osteosarcoma and Ewing’s sarcoma in childhood: a study of 305 cases by the Children’s Cancer Group. Cancer 83:1440–1448
Gelberg KH, Fitzgerald EF, Hwang S, Dubrow R (1997) Growth and development and other risk factors for osteosarcoma in children and young adults. Int J Epidmiol 26:272–278
Glasser DB, Duane K, Lane JM, Healey JH, Caparros-Sison B (1991) The effect of chemotherapy on growth in the skeletally immature individual. Clin Orthop Relat Res 262:93–100
Pendergrass TW, Foulkes MA, Robison LL, Nesbit ME (1984) Stature and Ewing’s sarcoma in childhood. Am J Pediatr Hematol Oncol 6:33–39
Ruza E, Sotillo E, Sierrasesumaga L, Azcona C, Patino-Garcia A (2003) Analysis of polymorphisms of the vitamin D receptor, estrogen receptor, and collagen Iα1 genes and their relationship with height in children with bone cancer. J Pediatr Hematol Oncol 25:780–786
Scranton PE, DeCicco FA, Totten RS, Yunis EJ (1975) Prognostic factors in osteosarcoma: a review of 2 years experience at the University of Pittsburgh Health Center Hospitals. Cancer 36:2179–2191
Troisi R, Masters MN, Joshipura K, Douglass C, Cole BF, Hoover RN (2006) Perinatal factors, growth and development, and osteosarcoma risk. Br J Cancer 95:1603–1607
Miller JJ (1978) The Inverse of the Freeman-Tukey double arcsine transformation. Am Stat 32:138
DerSimonian R, Laird N (1986) Meta-analysis in clinical trials. Control Clin Trials 7:177–188
Brockwell SE, Gordon IR (2001) A comparison of statistical methods for meta-analysis. Stat Med 20:825–840
Silva AM, Crubezy E, Cunha E (2009) Bone weight: new reference values based on a modern Portuguese indentified skeletal collection. Int J Osteoarchaeology 19:628–641
Acknowledgments
RS Arora is funded by a grant from the Paediatric Endowment Fund Christie Hospital NHS Foundation Trust and from the Teenage Cancer Trust. RD Alston and M Geraci are funded by grants from Cancer Research UK. T Eden is funded by the Teenage Cancer Trust. JM Birch is a Cancer Research UK Professorial Fellow at the University of Manchester.
Author information
Authors and Affiliations
Corresponding author
Electronic supplementary material
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Arora, R.S., Kontopantelis, E., Alston, R.D. et al. Relationship between height at diagnosis and bone tumours in young people: a meta-analysis. Cancer Causes Control 22, 681–688 (2011). https://doi.org/10.1007/s10552-011-9740-9
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10552-011-9740-9